Table 2. Results of linear modeling of age progression of MRS metabolites relative to normative values.
Region | Metabolite | Slope of Age [95% CI] | Test Statistic for Age (DF = 25) |
---|---|---|---|
LCSO | Creatine | 0.07 [0, 0.14] | t=2.02, p=0.05 |
Myo-inositol | 0.09 [−0.05, 0.23] | t=1.31, p=0.20 | |
Choline | 0.03 [0, 0.06] | t=2.21, p=0.04 | |
NAA | −0.25 [−0.37, −0.13] | t=−3.96, p<.001 | |
Glx | −0.04 [−0.27, 0.19] | t=−0.32, p=0.75 | |
PGM | Creatine | −0.27 [−0.39, −0.15] | t=−4.48, p<.001 |
Myo-inositol | −0.08 [−0.18, 0.02] | t=−1.52, p=0.14 | |
Choline | 0 [−0.03, 0.03] | t=−0.16, p=0.87 | |
NAA | −0.61 [−0.78, −0.45] | t=−7.44, p<.001 | |
Glx | −0.82 [−1.04, −0.6] | t=−7.36, p<.001 |